SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027825
Filing Date
2023-08-11
Accepted
2023-08-11 16:05:47
Documents
54
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 915247
2 ex31-1.htm EX-31.1 11649
3 ex31-2.htm EX-31.2 11647
4 ex32-1.htm EX-32.1 4969
10 GRAPHIC ex33-certificatetoaccompanya.jpg GRAPHIC 571940
11 GRAPHIC ex34-certificateofdesignatio.jpg GRAPHIC 570286
  Complete submission text file 0001493152-23-027825.txt   5943643

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE brtx-20230630.xsd EX-101.SCH 23829
6 XBRL CALCULATION FILE brtx-20230630_cal.xml EX-101.CAL 38541
7 XBRL DEFINITION FILE brtx-20230630_def.xml EX-101.DEF 116961
8 XBRL LABEL FILE brtx-20230630_lab.xml EX-101.LAB 226685
9 XBRL PRESENTATION FILE brtx-20230630_pre.xml EX-101.PRE 192314
48 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 794023
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 231164024
SIC: 8090 Services-Misc Health & Allied Services, NEC